mCODE Lite (mCODE-LITE)
0.1.0 - draft
mCODE Lite (mCODE-LITE), published by MITRE. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/CodeX-HL7-FHIR-Accelerator/mcode-lite/ and changes regularly. See the Directory of published versions
This page is under development and subject to change pending review feedback.
EOM participants are oncology PGPs that prescribe and administer chemotherapy for cancer. As of EOM Clinical Data Elements Guide 2.0, the model is centered on 6-month episodes of care triggered by receipt of a qualifying initiating cancer therapy for seven cancer types:
EOM further specifies conditional filtering of cancer subtypes. Namely, "low-risk" breast cancer and "low-intensity" prostate cancer. There is no formal SNOMED or ICD-10 code with such explicit descriptions. Therefore, the submission of an EOM cancer patient for either breast or prostate cancer may involve additional upstream logic that leverages PrimaryCancerCondition
and drug classes represented in CancerRelatedMedicationAdministration
.
EOM scopes further constraining TumorMarkerTest for contextual biomarkers relative to the seven scoped cancer types.
EOM specifies history of metastatic cancer as one element. To address this gap, mCODE created a dedicated profile called history of metastatic cancer. However, it is also possible that one could infer such a history that leverages PrimaryCancerCondition
with Condition.clinicalStatus = "resolved" and SecondaryCancerCondition
. Implementers should consider developing upstream logic that handles both representations.
The EOM IG specifier can collectively represent these requirements in 2 ways:
Partial examples are included in this IG for illustrative purposes:
TBD